KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001231919-26-000286 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 27, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
214,631
Total Value
$3,691,147.81
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Mar 25, 2026 | Sale | 174,485 | $16.95 | $2,957,520.75 | 5,129,500 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Mar 25, 2026 | Sale | 160 | $17.53 | $2,804.80 | 5,129,340 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Mar 26, 2026 | Sale | 21,386 | $17.76 | $379,815.36 | 5,107,954 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Mar 26, 2026 | Sale | 15,417 | $18.82 | $290,147.94 | 5,092,537 | Indirect | By Funds | View Details | |
10% Owner | Common Stock | โ | Mar 26, 2026 | Sale | 3,183 | $19.12 | $60,858.96 | 5,089,354 | Indirect | By Funds | View Details |